期刊文献+

急性白血病患者染色体核型分析 被引量:5

Chromosome analysis in patients with acute leukemia
下载PDF
导出
摘要 目的联合细胞形态学、免疫分型检测手段探讨染色体分析在急性白血病AL诊断及预后判断中的价值。方法 310例AL患者于治疗前采用骨髓直接法和(或)短期培养法,按常规进行染色体制备,用G显带技术分析中期细胞数10-30个,平均每例分析细胞20个,核型按《人类细胞遗传学国际命名法体制(ISCN)1995》进行描述。结果急性髓系白血病(AML)异常核型中,以t(8;21)和M2最多见,其次是t(15;17)和M3、inv(16)和M4Eo、t/del(11q23)和M5等。急性淋巴细胞系白血病(ALL)患者中异常检出率最高的是t(9;22),数目异常以超二倍体、多倍体常见。结论联合细胞形态学、免疫表型分析、染色体检查技术对于白血病的准确诊断、靶向治疗、判断预后具有重要意义。 Objective Combining with morphological and immunophenotypical means,to explore the role of chromosome analysis in diagnosis and prognosis of acute leukemia(AL).Methods A total of 310 bone marrow samples were taken at the diagnosis,the leukemic cells by using direct method or short-term culture harvested for karyotyping.For each sample,G-banding analysis was performed for 10 to 30 metaphase averaging 20 cells.According to the International System for Human Cytogenetics Nomenclature(ISCN 1995)describe karyotype.Results The most common karyotype abnormality in patients with acute myeloid leukemia(AML)was t(8;21) in M2 subtype.The next was t(15;17) in M3 subtype,inv(16) in M4Eo subtype and t/del(11q23) in M5 subtype respectively.t(9;22)was the most common change in patients with acute lymphoblastic leukemia.Structural chromosome abnormalities include hyperdiploid and polyploid change.Conclusion Morphological,immunophenotypical and chromosome techniques were useful not only for diagnosis and differentiation,but also for treatment and prognosis in these diseases.
出处 《中国实验诊断学》 2012年第3期465-467,共3页 Chinese Journal of Laboratory Diagnosis
基金 广西医科大学研究生创新课题(2011105981002M217)
关键词 急性白血病 染色体 异常 acute leukemia chromosome abnormality
  • 相关文献

参考文献4

二级参考文献20

  • 1Elaine S, Harris N, Stein H. Pathology and genetics of tumors of haematopietic and lymphoid tissues. France: IARC Press International Agency for Research on Cancer (IARC)69008 Lyon, France. 2001:76.
  • 2Udayakumar AM, Pathare AV, Al-Kindi S, et al. Cytogenetic, morphological and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia. Cancer Genet Cytogenet, 2007;177: 89 - 94.
  • 3Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev, 2004; 18:115 -156.
  • 4King ME, Rowe JM. Recent developments in acute myelogenous leukemia therapy. Oncologist, 2007 ; 12 ( Suppl 2 ) : 14 - 21.
  • 5Shaffer LG, Tommerup N. ISCN ( 2005 ). An International System for Human Cytogenetic Nomenclature. Switzerland: Karger Basel publication, 2005:55 - 83.
  • 6Onsten T, Girardi FM, Coelho GM, et al. Cytogenetic and morphological findings in 166 patients with de novo acute myeloid leukemia in southern. Brazil Cancer Genet Cytogenet, 2006 ; 170 : 167 - 170.
  • 7Klaus M, Haferlaeh T, Sehnittger S, et al. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1 and M2 : a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet, 2004; 155:47-56.
  • 8Litmanovich D, Zamir-Brill R, Jeison M, et al. Is inversion 16 a prerequisite and id trisomy 22 invariably associated with inversion 16 in AML-M4eo? Cancer Genet Cytogenet, 2000 ; 121 : 106.
  • 9Udayakumar AM, Pathare AV, Al-Kindi S,et al. Cytogenetic, morphological and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia. Cancer Genet Cytogenet. 2007 ; 177 : 89 - 94.
  • 10Kelly L M, Gilliland D G. Genetics of myeloid leukemias [J ]. Annu Rev Genomics Hum Genet, 2002,3 : 179- 198.

共引文献27

同被引文献40

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部